Therefore, ORs were determined separately for the breast cancer types for which there were sufficient numbers in both biallelic and monoallelic CHEK2 PV carriers: ductal invasive and DCIS (Fig. 3). This evidence concerns the gene CHEK2 and ductal breast carcinoma in situ.